BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16523511)

  • 1. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis.
    Cleland JC; Malik K; Thaisetthawatkul P; Herrmann DN; Logigian EL
    Muscle Nerve; 2006 Jun; 33(6):771-7. PubMed ID: 16523511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
    Thaisetthawatkul P; Logigian EL; Herrmann DN
    Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
    Van den Bergh PY; Piéret F
    Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.
    Cleland JC; Logigian EL; Thaisetthawatkul P; Herrmann DN
    Muscle Nerve; 2003 Aug; 28(2):189-93. PubMed ID: 12872323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.
    Stanton M; Pannoni V; Lewis RA; Logigian EL; Naguib D; Shy ME; Cleland J; Herrmann DN
    Muscle Nerve; 2006 Oct; 34(4):417-22. PubMed ID: 16823858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy.
    Al-Shekhlee A; Hachwi RN; Preston DC; Katirji B
    Muscle Nerve; 2005 Jul; 32(1):66-72. PubMed ID: 15880488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies.
    Isose S; Kuwabara S; Kokubun N; Sato Y; Mori M; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Sawai S; Kanai K; Hirata K; Misawa S;
    J Peripher Nerv Syst; 2009 Sep; 14(3):151-8. PubMed ID: 19909478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of the tibialis anterior CMAP duration in chronic inflammatory demyelinating polyneuropathy.
    Nodera H; Latov N; Carey B; Langsdorf J; Bedoya V; Tacheva S; Chin RL
    Clin Neurophysiol; 2012 Feb; 123(2):393-8. PubMed ID: 21767985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
    Wilson J; Chawla J; Fisher M
    J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study.
    Mitsuma S; Van den Bergh P; Rajabally YA; Van Parijs V; Martin-Lamb D; Sonoo M; Inaba A; Shimizu T; Isose S; Sato Y; Komori T; Misawa S; Kuwabara S;
    Clin Neurophysiol; 2015 Sep; 126(9):1805-10. PubMed ID: 25591830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very early electrodiagnostic findings in Guillain-Barré syndrome.
    Albertí MA; Alentorn A; Martínez-Yelamos S; Martínez-Matos JA; Povedano M; Montero J; Casasnovas C
    J Peripher Nerv Syst; 2011 Jun; 16(2):136-42. PubMed ID: 21692913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters.
    Isose S; Misawa S; Sonoo M; Shimuzu T; Oishi C; Shibuya K; Nasu S; Sekiguchi Y; Mitsuma S; Beppu M; Omori S; Komori T; Kokubun N; Inaba A; Hirashima F; Kuwabara S;
    J Clin Neurophysiol; 2014 Oct; 31(5):441-3. PubMed ID: 25271683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection.
    Uncini A; Foresti C; Frigeni B; Storti B; Servalli MC; Gazzina S; Cosentino G; Bianchi F; Del Carro U; Alfonsi E; Piccinelli SC; De Maria G; Padovani A; Filosto M; Ippoliti L
    Neurophysiol Clin; 2021 Mar; 51(2):183-191. PubMed ID: 33685769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
    Dionne A; Nicolle MW; Hahn AF
    Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of total duration of distal compound muscle action potential in demyelinating and axonal Guillain-Barre' syndrome.
    Ginanneschi F; Cioncoloni D; Capoccitti G; Volpi N; Ferretti F; Giannini F; Rossi A
    Neurol Res; 2023 Apr; 45(4):381-389. PubMed ID: 36403142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.
    Bromberg MB
    Muscle Nerve; 1991 Oct; 14(10):968-76. PubMed ID: 1944409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H
    Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis.
    Sathyaprabha TN; Pradhan C; Nalini A; Thennarasu K; Raju TR
    Acta Neurol Scand; 2010 Jun; 121(6):400-5. PubMed ID: 20070278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.